Corning to double production of glass vials for COVID vaccines to 150 million this year, holding 1.2 billion doses: WSJ
Corning Inc. is planning to increase production of glass vials for COVID-19 vaccines by 50% from prior targets, after receiving more federal funding, the Wall Street Journal reported on Friday. The glass maker is now expecting to produce 150 million vials this year, that will hold about 1.2 billion vaccine doses, the paper reported, citing Brendan Mosher, vice president and general manager of the company's pharmaceutical technologies business. The increased output is expected to ease tight supplies of the glass vials, which are essential to storing the Covid-19 vaccines that governments have been counting on to help end the pandemic. The Biden administration has secured more Covid-19 vaccine doses from Pfizer Inc. , Moderna Inc. and Johnson & Johnson so that the U.S. should have enough supply for all adults by the end of May.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.